Position in ARGX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$750,565
+$258,377 QoQ
Shares Held
809
+20.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#66
of 179 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $19,699,479 across 40 Biotechnology names. ARGX ranks #5 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,514 | $3,438,199 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,474 | $3,215,830 | |
| 3 | INCY |
Incyte Corp
|
7,759 | $879,560 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,770 | $833,853 | |
| 5 | ARGX |
Argenx SE
This page
|
809 | $750,565 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
3,045 | $733,753 | |
| 7 | ACAD |
Acadia Pharmaceuticals Inc
|
27,134 | $686,490 | |
| 8 | GMAB |
Genmab A/S
|
24,930 | $684,827 |
All Filings in ARGX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $750,565 | 809 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $492,188 | 674 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $608,847 | 724 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $443,273 | 601 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $297,658 | 540 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $320,198 | 541 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $338,865 | 551 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $286,218 | 528 | Shares | Sole | 2024-11-07 | |
| No filing history on record for this holder in this stock. | ||||||